19-7184640-GGAGAGAGAGAGA-GGAGAGAGAGAGAGAGAGAGA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000208.4(INSR):c.653-11_653-4dupTCTCTCTC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 9 hom., cov: 0)
Exomes 𝑓: 0.00050 ( 8 hom. )
Consequence
INSR
NM_000208.4 splice_region, intron
NM_000208.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -2.04
Publications
4 publications found
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 19-7184640-G-GGAGAGAGA is Benign according to our data. Variant chr19-7184640-G-GGAGAGAGA is described in ClinVar as Benign. ClinVar VariationId is 780508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00581 (827/142242) while in subpopulation EAS AF = 0.0199 (99/4982). AF 95% confidence interval is 0.0177. There are 9 homozygotes in GnomAd4. There are 391 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR,AD gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000208.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | MANE Select | c.653-11_653-4dupTCTCTCTC | splice_region intron | N/A | NP_000199.2 | |||
| INSR | NM_001079817.3 | c.653-11_653-4dupTCTCTCTC | splice_region intron | N/A | NP_001073285.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000302850.10 | TSL:1 MANE Select | c.653-4_653-3insTCTCTCTC | splice_region intron | N/A | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | TSL:1 | c.653-4_653-3insTCTCTCTC | splice_region intron | N/A | ENSP00000342838.4 | |||
| INSR | ENST00000598216.1 | TSL:1 | n.628-4_628-3insTCTCTCTC | splice_region intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.00580 AC: 824AN: 142152Hom.: 9 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
824
AN:
142152
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00118 AC: 163AN: 137742 AF XY: 0.00106 show subpopulations
GnomAD2 exomes
AF:
AC:
163
AN:
137742
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000499 AC: 616AN: 1233768Hom.: 8 Cov.: 17 AF XY: 0.000476 AC XY: 294AN XY: 617872 show subpopulations
GnomAD4 exome
AF:
AC:
616
AN:
1233768
Hom.:
Cov.:
17
AF XY:
AC XY:
294
AN XY:
617872
show subpopulations
African (AFR)
AF:
AC:
190
AN:
24746
American (AMR)
AF:
AC:
26
AN:
39554
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
23120
East Asian (EAS)
AF:
AC:
263
AN:
36436
South Asian (SAS)
AF:
AC:
12
AN:
70474
European-Finnish (FIN)
AF:
AC:
1
AN:
47250
Middle Eastern (MID)
AF:
AC:
5
AN:
3920
European-Non Finnish (NFE)
AF:
AC:
38
AN:
937134
Other (OTH)
AF:
AC:
55
AN:
51134
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00581 AC: 827AN: 142242Hom.: 9 Cov.: 0 AF XY: 0.00567 AC XY: 391AN XY: 68970 show subpopulations
GnomAD4 genome
AF:
AC:
827
AN:
142242
Hom.:
Cov.:
0
AF XY:
AC XY:
391
AN XY:
68970
show subpopulations
African (AFR)
AF:
AC:
683
AN:
36268
American (AMR)
AF:
AC:
26
AN:
14292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3404
East Asian (EAS)
AF:
AC:
99
AN:
4982
South Asian (SAS)
AF:
AC:
1
AN:
4496
European-Finnish (FIN)
AF:
AC:
0
AN:
9414
Middle Eastern (MID)
AF:
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
AC:
12
AN:
66284
Other (OTH)
AF:
AC:
6
AN:
1942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Jun 01, 2020
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.